Caribou Biosciences (CRBU) Short Interest Ratio & Short Volume $2.49 +0.05 (+2.05%) (As of 07/26/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Caribou Biosciences Short Interest DataCurrent Short Interest11,640,000 sharesPrevious Short Interest10,250,000 sharesChange Vs. Previous Month+13.56%Dollar Volume Sold Short$24.79 millionShort Interest Ratio4.6 Days to CoverLast Record DateJuly 15, 2024Outstanding Shares90,318,000 sharesFloat Size79,880,000 sharesShort Percent of Float14.57%Today's Trading Volume1,141,748 sharesAverage Trading Volume2,047,926 sharesToday's Volume Vs. Average56% Short Selling Caribou Biosciences ? Sign up to receive the latest short interest report for Caribou Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCRBU Short Interest Over TimeCRBU Days to Cover Over TimeCRBU Percentage of Float Shorted Over Time Ad Stansberry ResearchGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all $20,000 of his wife's 401k into shares of just ONE stock. Everyone on Wall Street said he was crazy. But a year later, that $20,000 in his wife's account was worth $120,000. Today, he says: "If you thought the dot-com mania was intense, what's about to happen in the coming weeks could be even crazier and could open up a new window of opportunity for 500%-plus gains."Click here now to watch this exclusive interview Caribou Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/202411,640,000 shares $24.79 million +13.6%14.6%4.6 $2.13 6/30/202410,250,000 shares $16.81 million -16.5%12.8%4.4 $1.64 6/15/202412,270,000 shares $21.96 million +6.6%15.4%5.3 $1.79 5/31/202411,510,000 shares $33.15 million +9.7%14.4%5.2 $2.88 5/15/202410,490,000 shares $38.18 million -1.4%13.1%5.6 $3.64 4/30/202410,640,000 shares $38.62 million -6.2%13.4%6.6 $3.63 Get the Latest News and Ratings for CRBU and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Caribou Biosciences and its competitors with MarketBeat's FREE daily newsletter. 4/15/202411,340,000 shares $46.15 million +11.2%14.2%7.1 $4.07 3/31/202410,200,000 shares $52.43 million +1.3%12.9%6.2 $5.14 3/15/202410,070,000 shares $54.08 million +7.2%12.7%6.1 $5.37 2/29/20249,390,000 shares $74.27 million -3.1%12.1%6.1 $7.91 2/15/20249,690,000 shares $67.83 million -4.3%12.5%6.2 $7.00 1/31/202410,120,000 shares $62.04 million +2.6%13.6%6.1 $6.13 1/15/20249,860,000 shares $53.64 million +2.3%13.2%5.6 $5.44 12/31/20239,640,000 shares $55.24 million -3.0%12.9%5.9 $5.73 12/15/20239,940,000 shares $60.53 million +0.5%13.7%6.5 $6.09 11/30/20239,890,000 shares $58.05 million +10.5%13.7%6 $5.87 11/15/20238,950,000 shares $41.80 million -8.5%12.4%5.3 $4.67 10/31/20239,780,000 shares $35.50 million +24.4%12.9%6 $3.63 10/15/20237,860,000 shares $32.93 million -28.9%10.4%5.3 $4.19 9/30/202311,050,000 shares $52.82 million +34.6%14.6%5.7 $4.78 9/15/20238,210,000 shares $48.11 million +20.9%10.8%2.4 $5.86 8/31/20236,790,000 shares $39.99 million -0.7%9.1%2.1 $5.89 8/15/20236,840,000 shares $45.01 million -6.2%9.2%2.2 $6.58 7/31/20237,290,000 shares $52.42 million -11.1%11.4%2.4 $7.19 7/15/20238,200,000 shares $51.66 million +31.8%12.8%2.9 $6.30 6/30/20236,220,000 shares $26.44 million -17.9%11.6%2.6 $4.25 6/15/20237,580,000 shares $34.87 million -4.3%14.2%10.1 $4.60 5/31/20237,920,000 shares $34.93 million +5.6%14.8%13.1 $4.41 5/15/20237,500,000 shares $33.75 million +9.2%14.0%13.9 $4.50 4/30/20236,870,000 shares $29.54 million +22.0%12.8%13.8 $4.30 4/15/20235,630,000 shares $25.79 million +7.9%10.5%11.1 $4.58 3/31/20235,220,000 shares $27.72 million +10.8%9.8%10.9 $5.31 3/15/20234,710,000 shares $24.30 million +10.1%8.8%9.2 $5.16 2/28/20234,280,000 shares $26.07 million -5.5%8.0%8.2 $6.09 2/15/20234,530,000 shares $30.62 million +3.7%8.5%8.4 $6.76 1/31/20234,370,000 shares $31.51 million No Change8.6%8 $7.21 1/15/20234,370,000 shares $31.55 million +14.7%8.6%7.6 $7.22 12/30/20223,810,000 shares $23.93 million +10.4%7.5%6.6 $6.28 12/15/20223,450,000 shares $26.67 million +3.3%6.8%6.1 $7.73 11/30/20223,340,000 shares $31.10 million +1.8%6.6%5.1 $9.31Elon to Transform U.S. Economy? (Ad)A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. 11/15/20223,280,000 shares $33.13 million -9.4%6.5%4.9 $10.10 10/31/20223,620,000 shares $35.26 million -8.8%7.2%4.8 $9.74 10/15/20223,970,000 shares $37.12 million -1.5%7.8%5.2 $9.35 9/30/20224,030,000 shares $42.52 million +39.9%8.0%5.5 $10.55 9/15/20222,880,000 shares $36.84 million +15.2%5.7%3.9 $12.79 8/31/20222,500,000 shares $24.68 million -14.4%4.9%3.3 $9.87 8/15/20222,920,000 shares $29.26 million -24.4%5.8%3.8 $10.02 7/31/20223,860,000 shares $31.34 million +5.8%7.7%4.5 $8.12 7/15/20223,650,000 shares $26.13 million No Change7.3%4.4 $7.16 6/30/20223,650,000 shares $19.82 million +8.0%7.3%4.5 $5.43 6/15/20223,380,000 shares $17.91 million +0.6%6.8%4.3 $5.30 5/31/20223,360,000 shares $27.99 million +33.9%6.7%4.6 $8.33 5/15/20222,510,000 shares $22.51 million +7.7%5.1%3.7 $8.97 4/30/20222,330,000 shares $17.24 million -2.9%4.9%4.4 $7.40 4/15/20222,400,000 shares $19.54 million +1.7%5.0%4.4 $8.14 3/31/20222,360,000 shares $21.66 million +54.3%5.0%3.9 $9.18 3/15/20221,530,000 shares $13.11 million -53.4%3.2%2.5 $8.57 2/28/20223,280,000 shares $32.73 million +7.5%6.9%6.5 $9.98 2/15/20223,050,000 shares $35.35 million +1.3%6.5%6.1 $11.59 1/31/20223,010,000 shares $32.30 million +20.4%6.4%6.5 $10.73 1/15/20222,500,000 shares $29.03 million -5.3%5.3%6 $11.61 12/31/20212,640,000 shares $39.84 million +15.8%5.6%6.8 $15.09 12/15/20212,280,000 shares $38.51 million +18.1%4.8%5.5 $16.89 11/30/20211,930,000 shares $35.88 million +25.3%4.1%3.8 $18.59 11/15/20211,540,000 shares $33.46 million +32.8%3.3%2.7 $21.73 10/29/20211,160,000 shares $25.65 million -9.4%2.5%1.7 $22.11 10/15/20211,280,000 shares $26.68 million -22.4%2.7%1.7 $20.84 9/30/20211,650,000 shares $39.39 million +27.9%3.5%1.7 $23.87 9/15/20211,290,000 shares $35.54 million +29.0%2.8%1.2 $27.55 8/31/20211,000,000 shares $27.20 million +67.0%2.2%0.9 $27.20 8/13/2021598,800 shares $14.51 million No Change1.4%0.5 $24.23 CRBU Short Interest - Frequently Asked Questions What is Caribou Biosciences' current short interest? Short interest is the volume of Caribou Biosciences shares that have been sold short but have not yet been closed out or covered. As of July 15th, investors have sold 11,640,000 shares of CRBU short. 14.57% of Caribou Biosciences' shares are currently sold short. Learn More on Caribou Biosciences' current short interest. What is a good short interest ratio for Caribou Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CRBU shares currently have a short interest ratio of 5.0. Learn More on Caribou Biosciences's short interest ratio. Which institutional investors are shorting Caribou Biosciences? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Caribou Biosciences: PEAK6 Investments LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Caribou Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 14.57% of Caribou Biosciences' floating shares are currently sold short. Is Caribou Biosciences' short interest increasing or decreasing? Caribou Biosciences saw a increase in short interest in the month of July. As of July 15th, there was short interest totaling 11,640,000 shares, an increase of 13.6% from the previous total of 10,250,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Caribou Biosciences' float size? Caribou Biosciences currently has issued a total of 90,318,000 shares. Some of Caribou Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Caribou Biosciences currently has a public float of 79,880,000 shares. How does Caribou Biosciences' short interest compare to its competitors? 14.57% of Caribou Biosciences' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Caribou Biosciences: Monte Rosa Therapeutics, Inc. (6.70%), Foghorn Therapeutics Inc. (4.01%), bluebird bio, Inc. (28.14%), Vaxart, Inc. (7.00%), Cellectis S.A. (0.80%), Sangamo Therapeutics, Inc. (6.13%), Precision BioSciences, Inc. (7.60%), Atara Biotherapeutics, Inc. (13.40%), Kezar Life Sciences, Inc. (1.58%), Stoke Therapeutics, Inc. (19.76%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.13 billion), Royal Caribbean Cruises Ltd. ($2.77 billion), Moderna, Inc. ($2.76 billion), Coinbase Global, Inc. ($2.36 billion), Rivian Automotive, Inc. ($2.22 billion), Paychex, Inc. ($2.02 billion), Tractor Supply ($1.81 billion), Enphase Energy, Inc. ($1.65 billion), Chesapeake Energy Co. ($1.62 billion), and Lululemon Athletica Inc. ($1.58 billion). View all of the most shorted stocks. What does it mean to sell short Caribou Biosciences stock? Short selling CRBU is an investing strategy that aims to generate trading profit from Caribou Biosciences as its price is falling. CRBU shares are trading up $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Caribou Biosciences? A short squeeze for Caribou Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CRBU, which in turn drives the price of the stock up even further. How often is Caribou Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CRBU, twice per month. The most recent reporting period available is July, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Monte Rosa Therapeutics Short Interest Data Foghorn Therapeutics Short Interest Data bluebird bio Short Interest Data Vaxart Short Interest Data Cellectis Short Interest Data Sangamo Therapeutics Short Interest Data Precision BioSciences Short Interest Data Atara Biotherapeutics Short Interest Data Kezar Life Sciences Short Interest Data Stoke Therapeutics Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CRBU) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredThe #1 Crypto for 2024 (3 Cent Coin)Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredDon't Pay a Dime for Marc Lichtenfeld's Top AI PicksUsually, you'd have to plunk down a hefty sum to get your hands on Marc Lichtenfeld's latest income research.....The Oxford Club | SponsoredThe asset beating inflation by 4xCentral Bank Gold Heist In Progress Central banks are buying gold at record rates... and billionaire invest...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Caribou Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Caribou Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.